mass cytometry Maternal Blood Proteomic, Metabolomic Changes Could Predict Onset of Labor About two to four weeks before labor starts, changes affecting the maternal metabolome, proteome, and immunome occur, a new study found. Fluidigm CEO Lays Out Plan for 'Durable' Diagnostics, Clinical Business Post-COVID Premium Fluidigm CEO Chris Linthwaite said the company aims to further penetrate the diagnostic and clinical markets with both its microfluidics and mass cytometry businesses. Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth The firm also announced a COVID-19 testing deal with George Mason University and a CyTOF supply and distribution agreement with Zhejiang PuLuoTing Health Technology in China. ImmunoScape, Johns Hopkins Team Profiles T Cell Response in COVID-19 Patients Premium The researchers identified phenotypes of SARS-CoV-2-specific T cells as well as viral epitopes involved in T cell response that could aid future vaccine design. Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing Fluidigm tallied $39.9 million in revenues compared to $26.5 million a year ago, and well above analysts' consensus estimate of $32.5 million. Aug 10, 2020 T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma Aug 4, 2020 Fluidigm, De Novo Software Ink Distribution Deal Jul 14, 2020 Newly Proposed B Cell Atlas Identifies 12 Unique Subsets May 7, 2020 Fluidigm Q1 Revenues Fall 8 Percent Apr 30, 2020 Washington University, BostonGene Expand Kidney Cancer Research Collaboration Feb 26, 2020 Fluidigm Acquires Cytometry Sample Prep Firm InstruNor for $7.2M Feb 10, 2020 Fluidigm Reports Flat Q4 Revenues Jan 24, 2020 Federal Court Whittles Down Fluidigm Lawsuit Against IonPath Jan 21, 2020 Imaging Mass Cytometry Uncovers Novel Breast Cancer Subgroups Associated With Outcomes Jan 14, 2020 Fluidigm Anticipates Flat Q4 Revenues Nov 5, 2019 Fluidigm Q3 Revenues Fall 9 Percent on Mass Cytometry Weakness Sep 10, 2019 Fluidigm Sues IonPath for Patent Infringement, Interference Aug 1, 2019 Fluidigm Q2 Revenues Grow 7 Percent; Stock Tumbles on Microfluidics Weakness, Soft Guidance May 3, 2019 Fluidigm Q1 Revenues Soar 19 Percent Apr 11, 2019 Fluidigm's New Immune Cell Profiling Assay Could Boost Use of Mass Cytometry Premium Feb 7, 2019 Fluidigm Q4 Revenues Grow 17 Percent on Mass Cytometry Strength Nov 1, 2018 Fluidigm Q3 Revenues Up 17 Percent Oct 9, 2018 10,000 Immunomes Project Establishes Initial Baseline for Healthy Immune System Sep 10, 2018 Fluidigm, Visiopharm Ink Mass Cytometry Comarketing Pact Aug 30, 2018 Cytobank Aims to Improve Cytometry Informatics, Starting With Immunotherapy, Single-Cell Analysis Premium Load More Breaking News Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.